Innate Pharma (IPHA) Other Operating Expenses (2023 - 2025)

Innate Pharma has reported Other Operating Expenses for 3 years, with the latest figure at $1164.0 in Q4 2025.

• For the quarter ending Q4 2025, Other Operating Expenses changed N/A year-over-year to $1164.0; the trailing twelve-month figure through Dec 2025 stood at $2240.9 (up 108.09% YoY), and the FY2025 full-year result was -$1164.0, changed N/A from the prior year.
• Other Operating Expenses for Q4 2025 stood at $1164.0, up from -$0.0 in the prior quarter.
• The five-year high for Other Operating Expenses was $1164.0 in Q4 2025, with the low at -$0.0 in Q2 2025.
• Historically, Other Operating Expenses has averaged $560.23 across 3 years, with a median of $538.44 in 2023.
• Annual changes were most pronounced in 2024 — Other Operating Expenses surged 14453740380100.0% — and 2025, when it tumbled 100.0%.
• Innate Pharma's Other Operating Expenses stood at $0.0 in 2023, then surged by 14453740380100.0% to $1076.9 in 2024, then climbed by 8.09% to $1164.0 in 2025.
• The last three Other Operating Expenses figures came in at $1164.0 (Q4 2025), -$0.0 (Q2 2025), and $1076.9 (Q2 2024), per Business Quant data.